QuiVad

Home / France / Innate Pharma

Innate Pharma

No short position is open on this share today.

Follow

Evolution of the disclosed total

0%1%
Oct 2025Jan 2026Apr 2026Jul 2026
Sum of open short positions, as % of capital. Hover or tap the curve to see which funds make it up.
The whole history, peaking at 4.07% on April 4, 2017. The shaded band is the year shown above.

April 15, 2014 today

Open positions

No fund discloses a short position on this share today. The history below keeps the trace of the ones that existed.

History of disclosures

330 disclosures on record for this share.
DateFund% of capitalEnd of publication
February 20, 2017Marshall Wace LLP1.09%January 4, 2018
February 13, 2017GSA Capital Partners LLP0.69%May 2, 2017
February 8, 2017Citadel Advisors II LLC0.49%February 10, 2017
February 7, 2017Great Point Partners, LLC0.79%March 13, 2017
February 6, 2017Citadel Advisors II LLC0.53%February 10, 2017
February 2, 2017GSA Capital Partners LLP0.71%May 2, 2017
January 13, 2017GSA Capital Partners LLP0.69%May 2, 2017
January 3, 2017Marshall Wace LLP1.17%January 4, 2018
January 3, 2017GSA Capital Partners LLP0.70%May 2, 2017
December 30, 2016Marshall Wace LLP1.28%January 4, 2018
December 29, 2016Marshall Wace LLP1.37%January 4, 2018
December 27, 2016GSA Capital Partners LLP0.69%May 2, 2017
December 20, 2016GSA Capital Partners LLP0.70%May 2, 2017
December 19, 2016GSA Capital Partners LLP0.69%May 2, 2017
December 15, 2016Marshall Wace LLP1.41%January 4, 2018
December 12, 2016Marshall Wace LLP1.33%January 4, 2018
December 8, 2016Marshall Wace LLP1.24%January 4, 2018
December 7, 2016Marshall Wace LLP1.18%January 4, 2018
November 9, 2016Great Point Partners, LLC0.93%March 13, 2017
November 7, 2016Marshall Wace LLP1.02%January 4, 2018
November 3, 2016Marshall Wace LLP0.93%January 4, 2018
November 2, 2016Citadel Advisors II LLC0.48%November 4, 2016
October 31, 2016Marshall Wace LLP0.81%January 4, 2018
October 28, 2016Marshall Wace LLP0.77%January 4, 2018
October 28, 2016Citadel Advisors II LLC0.50%November 4, 2016
October 26, 2016Great Point Partners, LLC0.83%March 13, 2017
October 26, 2016Marshall Wace LLP0.61%January 4, 2018
October 19, 2016GSA Capital Partners LLP0.71%May 2, 2017
October 19, 2016Millennium International Management LP0.48%October 21, 2016
October 17, 2016Numeric Investors LLC0.47%October 19, 2016
October 14, 2016Numeric Investors LLC0.57%October 19, 2016
October 14, 2016Millennium International Management LP0.56%October 21, 2016
October 7, 2016Numeric Investors LLC0.70%October 19, 2016
October 6, 2016GSA Capital Partners LLP0.61%May 2, 2017
October 5, 2016Millennium International Management LP0.64%October 21, 2016
October 5, 2016Numeric Investors LLC0.64%October 19, 2016
October 4, 2016Great Point Partners, LLC0.74%March 13, 2017
October 4, 2016Millennium International Management LP0.73%October 21, 2016
September 29, 2016GSA Capital Partners LLP0.50%May 2, 2017
September 19, 2016Millennium International Management LP0.91%October 21, 2016
September 14, 2016Great Point Partners, LLC0.60%March 13, 2017
September 13, 2016Millennium International Management LP0.80%October 21, 2016
September 8, 2016Millennium International Management LP0.78%October 21, 2016
September 7, 2016Millennium International Management LP0.80%October 21, 2016
September 6, 2016Millennium International Management LP0.78%October 21, 2016
September 1, 2016Millennium International Management LP0.89%October 21, 2016
August 24, 2016Millennium International Management LP0.90%October 21, 2016
August 17, 2016Millennium International Management LP0.83%October 21, 2016
August 10, 2016Millennium International Management LP0.77%October 21, 2016
August 8, 2016Millennium International Management LP0.81%October 21, 2016

Other companies sold short in France

Download as CSV

Cite this page

The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.

QuiVad, Innate Pharma, source AMF, data as at January 28, 2022, https://www.quivad.com/action/innate-pharma?page=4